MX2010004025A - Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos. - Google Patents

Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos.

Info

Publication number
MX2010004025A
MX2010004025A MX2010004025A MX2010004025A MX2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A MX 2010004025 A MX2010004025 A MX 2010004025A
Authority
MX
Mexico
Prior art keywords
methods
sdf
antagonists
same
glycosaminoglycan
Prior art date
Application number
MX2010004025A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Kungl
Isa Werner
Jason Slingsby
Simi Ali
John A Kirby
Original Assignee
Protaffin Biotechnologie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protaffin Biotechnologie Ag filed Critical Protaffin Biotechnologie Ag
Publication of MX2010004025A publication Critical patent/MX2010004025A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/522Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2010004025A 2007-10-24 2008-10-23 Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos. MX2010004025A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07450189A EP2053060A1 (en) 2007-10-24 2007-10-24 SDF-1-based glyocosaminoglycan antagonists and methods of using same
PCT/EP2008/008960 WO2009053064A1 (en) 2007-10-24 2008-10-23 Sdf-1-based glycosaminoglycan antagonists and methods of using same

Publications (1)

Publication Number Publication Date
MX2010004025A true MX2010004025A (es) 2010-04-30

Family

ID=39133777

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004025A MX2010004025A (es) 2007-10-24 2008-10-23 Antagonistas de glucosaminoglicano basados en sdf-1 y metodos de uso de los mismos.

Country Status (13)

Country Link
US (1) US20100298203A1 (enExample)
EP (2) EP2053060A1 (enExample)
JP (1) JP2011501675A (enExample)
KR (1) KR20100085041A (enExample)
CN (1) CN101835800A (enExample)
AU (1) AU2008315614A1 (enExample)
BR (1) BRPI0818009A2 (enExample)
CA (1) CA2702502A1 (enExample)
EA (1) EA201000688A1 (enExample)
IL (1) IL205300A0 (enExample)
MX (1) MX2010004025A (enExample)
NZ (1) NZ584278A (enExample)
WO (1) WO2009053064A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475380A1 (en) * 2009-09-11 2012-07-18 Protaffin Biotechnologie AG Composition for treatment of cxcl8-mediated lung inflammation
CN102094043B (zh) * 2010-11-23 2012-11-07 山东农业大学 猪趋化因子cxcl12基因及其应用
US20140073557A1 (en) 2011-03-16 2014-03-13 Protaffin Biotechnologie Ag Fgfri-based antagonists with improved glycosaminoglycan affinity and methods of using same
WO2013007704A2 (en) 2011-07-08 2013-01-17 Protaffin Biotechnologie Ag Novel sdf-1-based glycosaminoglycan antagonist and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364894A (en) * 1993-03-31 1994-11-15 Tremco, Inc. Emulsification of asphalt and modified asphalt with primary emulsifier polymers comprised of acrylic acid type monomers
EP0915969A4 (en) * 1996-04-02 2002-04-17 Progenics Pharm Inc SUPPRESSION OF CD4 + CELL INFECTION BY HIV
DE60103052T2 (de) * 2000-05-09 2005-03-03 The University Of British Columbia, Vancouver Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
US7662221B2 (en) * 2006-06-23 2010-02-16 Johns Manville Spray applied building wrap coating material, spray applied building wrap, and building construction assembly
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine

Also Published As

Publication number Publication date
EP2053060A1 (en) 2009-04-29
US20100298203A1 (en) 2010-11-25
WO2009053064A1 (en) 2009-04-30
EA201000688A1 (ru) 2010-10-29
AU2008315614A1 (en) 2009-04-30
WO2009053064A8 (en) 2009-07-16
NZ584278A (en) 2012-06-29
KR20100085041A (ko) 2010-07-28
CN101835800A (zh) 2010-09-15
BRPI0818009A2 (pt) 2015-04-14
JP2011501675A (ja) 2011-01-13
EP2203473A1 (en) 2010-07-07
CA2702502A1 (en) 2009-04-30
IL205300A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
MY165582A (en) Azetidine and cyclobutane derivatives as jak inhibitors
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
IN2012DN02730A (enExample)
IN2012DN00754A (enExample)
MX2020012426A (es) Anticuerpos anti-cd38.
IL183160A0 (en) Indazole-carboxamide compounds
TW200714604A (en) Substituted heterocycles and the uses thereof
MX364200B (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2009008787A (es) Moduladores 2-aminopirimidina del receptor de histamina h4.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
EA201170659A1 (ru) Антитела к рецептору ii tgf-вета
TW200602089A (en) Sugar coatings and methods therefor
WO2006058868A8 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
MX2009009153A (es) Pirano-pirazol-aminas.
EP2004188A4 (en) BENZOIMIDAZOLE-2-YL PYRIDINES AS HISTAMINE H4 RECEPTOR MODULATORS
MX2012006430A (es) Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide.
WO2011116212A3 (en) Bone morphogenetic protein receptor binding agents and methods of their use
MX2012013735A (es) Isoformas de neuregulina, polipeptidos de neuregulina y usos de los mismos.
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
TW200635597A (en) Substituted pteridines for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal